Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. [electronic resource]
- Haematologica Mar 2007
- 342-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1592-8721
10.3324/haematol.10385 doi
Adolescent Adult Aged Aged, 80 and over Antigens, CD--biosynthesis Antigens, Differentiation, Myelomonocytic--biosynthesis Antigens, Neoplasm--biosynthesis Antineoplastic Combined Chemotherapy Protocols--therapeutic use Blood Cell Count Burkitt Lymphoma--blood CD13 Antigens--biosynthesis Cell Lineage Cohort Studies Combined Modality Therapy Cranial Irradiation Cytarabine--administration & dosage Daunorubicin--administration & dosage Disease-Free Survival Drug Resistance, Multiple Drug Resistance, Neoplasm Female Humans Immunophenotyping Leukemia-Lymphoma, Adult T-Cell--blood Male Middle Aged Multicenter Studies as Topic--statistics & numerical data Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood Prognosis Radiotherapy, Adjuvant Randomized Controlled Trials as Topic--statistics & numerical data Remission Induction Sialic Acid Binding Ig-like Lectin 3